Condition
Functional Gastrointestinal Disorder
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Active Not Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02689648Active Not RecruitingPrimary
Long Term Follow up on Functional Gastrointestinal Disorder (FGID)
NCT00164775Phase 3CompletedPrimary
The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia
NCT01287286Phase 2Unknown
Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy
Showing all 3 trials